RxDoctor Payments Data

David Hulet, MD

Hand Surgery · Spokane, WANPI 1841644630

Payments from drug & device makers

What this record shows

Arthrex accounts for 62.4% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2024 at $1,403 and has fallen 95.9% since, to $57 in 2025.

$2,010in general payments, 2019–2025

Across 24 payments — averaging $83.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$1K
  • Axogen$412
  • Summit Surgical Corp.$148
  • Endo Pharmaceuticals Inc.$138
  • Vertex$57

What the payments were for

  • Travel & lodging$85543%
  • Food & beverage$1,15557%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Arthrex18$1,255
Axogen2$412
Summit Surgical Corp.1$148
Endo Pharmaceuticals Inc.1$138
Vertex2$57

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,010 in reported general payments places this provider in the 60th percentile of 75 hand surgery providers in Washington.

See all hand surgery providers in Washington

Medicare billing

Part B allowed, 2024
$117,396
Medicare patients
190
Services billed
935

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl67$273
Tramadol Hcl11$20

Paid to pharmacies, not to this prescriber.

Other hand surgery in Spokane

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →